Eastwood Bio-Medical Canada Inc. reported earnings results for the second quarter and six months ended April 30, 2022. For the second quarter, the company reported sales was CAD 0.280212 million compared to CAD 0.268736 million a year ago. Revenue was CAD 0.302612 million compared to CAD 0.285879 million a year ago. Net loss was CAD 0.029266 million compared to CAD 0.230495 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
For the six months, sales was CAD 0.586755 million compared to CAD 0.452631 million a year ago. Revenue was CAD 0.633624 million compared to CAD 0.485128 million a year ago. Net loss was CAD 0.039602 million compared to CAD 0.422055 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.